Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: February 24, 2010
Reporting Period: Fourth quarter and full fiscal year 2009
This filing serves as a cover document announcing the release of the Company's fourth quarter and twelve-month earnings results for 2009. The detailed financial data is contained in an attached Investor News release (Exhibit 99.1), which is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the attached Exhibit 99.1 (Investor News).
The Company utilizes the following non-GAAP financial measures to supplement GAAP results:
- EBITDA: Operating income excluding interest, taxes, depreciation, and amortization.
- Free Cash Flow: A measure of cash generation after capital expenditures.
Reconciliations between these non-GAAP measures and the most comparable GAAP measures are included in the attached Investor News and the Cash Flow Statement.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It only confirms that the results for the fourth quarter and full year 2009 have been issued.
Guidance, Outlook, and Risks
Management Commentary: Management states that the inclusion of non-GAAP measures provides consistency and comparability with prior periods and enhances the user's understanding of current performance and future prospects. However, the Company explicitly notes that these measures should not be used as a substitute for or considered superior to GAAP financial measures.
Risks and Contingencies: No specific risks or contingencies are detailed in the cover text of this Form 6-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor News) for specific revenue, net income, and EBITDA figures for Q4 and FY 2009.
- Verify the reconciliation of non-GAAP measures (EBITDA and Free Cash Flow) to GAAP measures as required by Regulation G.
- Confirm the specific year-over-year percentage changes in key metrics, as these are not stated in the cover letter.
- Check for any forward-looking guidance or updated outlook provided in the attached Investor News.